Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant

Abstract

Protein/subunit vaccines often require external adjuvants to induce protective immunity. Due to the safety concern of chemical adjuvants, physical adjuvants were recently explored to boost vaccination. Physical adjuvants use physical energies rather than chemicals to stimulate tissue stress and endogenous danger signal release to boost vaccination. Here we present the safety and potency of non-invasive radiofrequency treatment to boost intradermal vaccination in murine models. We show non-invasive radiofrequency can increase protein antigen-induced humoral and cellular immune responses with adjuvant effects comparable to widely used chemical adjuvants. Radiofrequency adjuvant can also safely boost pandemic 2009 H1N1 influenza vaccination with adjuvant effects comparable to MF59-like AddaVax adjuvant. We find radiofrequency adjuvant induces heat shock protein 70 (HSP70) release and activates MyD88 to mediate the adjuvant effects. Physical radiofrequency can potentially be a safe and potent adjuvant to augment protein/subunit vaccine-induced humoral and cellular immune responses.

COVID-19 Vaccine: A comprehensive status report

“…An adjuvant may enhance the biological half-life of the antigenic material, or it may ameliorate the immunomodulatory cytokine response. The addition of an adjuvant, therefore, helps in overcoming the shortcomings of the protein subunit vaccines ( Cao et al, 2018 ). The S protein of the SARS-CoV-2 is the most suitable antigen to induce the neutralizing antibodies against the pathogen.…”

Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface

“…To explore whether FH VLPs stimulated in vivo DC maturation, 5 µg FH VLPs, 3.7 µg FljB, and 1.2 µg HBc VLPs (equal moles) were intradermally injected into lateral back skin of C57BL/6 mice. Skin was dissected 24 hours later and single-cell suspensions were prepared as in our previous report [24]. Skin cells were then similarly stained with fluorescence-conjugated anti-CD11c, anti-CD40, anti-CD80, and anti-CD86 followed by flow cytometry analysis as above.…”

Immunogenicity of gold nanoparticle-based truncated ORF2 vaccine in mice against Hepatitis E virus

“…Recombinant subunit vaccines based on protein antigens are poorly immunogenic when used alone, therefore, require adjuvants to increase the immune response (Cao et al 2018). Among all commonly used adjuvant, alum is the only licensed adjuvant for human use (Gupta 1998).…”